DOCSLIB.ORG

Reportable Infectious Diseases in Maine 2015 Summary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Reportable Infectious Diseases in Maine 2015 Summary Reportable Infectious Diseases in Maine Hepatitis C Tuberculosis CRE Shigella Chlamydia Rabies Giardia Varicella Influenza-like Illness GI Outbreak Foodborne Illness Legionella HIV West Nile Campylobacteriosis Strep. pneumoniae MRSA Pertussis H.flu Streptococcal Toxic Shock Salmonella Rabies PEP Arboviral Lyme Hepatitis B 2015 Summary Reportable Infectious Diseases in Maine 2015 Summary Editor: Sara Robinson, MPH Contributors: Division of Infectious Disease Staff 1 Maine Center for Disease Control and Prevention (Maine CDC) annually publishes a report on infectious diseases in Maine. This report is prepared by the Division of Disease Control and is intended to provide an overview of notifiable infectious diseases of public health importance in Maine. We could not produce this report without the continued support of our healthcare and public health partners throughout the state. We greatly appreciate all of the laboratories, healthcare providers, childcare centers, school nurses, veterinarians, and others who provide disease surveillance information. Considerable time is spent assisting Maine CDC with infectious disease investigations and disease control measures that affect Maine residents. Public health partners’ active and critical role in the infectious disease surveillance cycle informs statewide policies and programs that protect our residents from infectious diseases through health promotion, disease prevention, early detection, containment, and treatment. We appreciate and encourage your vigilance in the effort to protect the people of Maine through timely, complete, and accurate notifiable infectious disease reporting. It is through these collaborative efforts that we are able to respond to emerging infectious disease threats and prevent outbreaks. We hope you find this report useful as we all work to protect and promote the health of Maine’s residents. As always, we welcome your feedback on how we can provide more useful disease information to you, our partners. For more information on what, when, and how to report infectious diseases please see Appendix J (Notifiable Conditions List) of this report, visit our website at www.mainepublichealth.gov, or call 1-800- 821-5821. Christopher Pezzullo, DO Lori Wolanski, MPH State Health Officer Director, Division of Disease Control Maine Center for Disease Control and Prevention Maine Center for Disease Control and Prevention 2 Table of Contents Introduction ................................................................................................................................. 5 Counts of Selected Reportable Diseases by Year, Maine 2006-2015 ................................ 8 Rates of Selected Reportable Diseases by Year, Maine 2006-2015 .................................. 10 Selected Reportable Disease, Maine, 2015 and Five Year Median ................................... 12 Selected Reportable Diseases by County, Maine, 2015…………………………….. ........... 13 Selected Reportable Diseases by District, Maine, 2015 .................................................... 19 Selected Reportable Diseases by Race and Ethnicity, Maine, 2015 .................................. 23 Outbreaks by County, Maine, 2015 ................................................................................... 25 Diseases Anaplasma phagocytophilum ............................................................................................ 27 Babesiosis ......................................................................................................................... 28 Campylobacteriosis ........................................................................................................... 29 Carbapenem-resistant Enterobacteriaceae (CRE) ............................................................ 30 Chikungunya virus ............................................................................................................. 31 Chlamydia ......................................................................................................................... 32 Creutzfeldt-Jakob Disease ................................................................................................ 33 Cryptosporidiosis ............................................................................................................... 34 Cyclosporiasis ................................................................................................................... 35 Dengue ............................................................................................................................. 36 Eastern Equine Encephalitis (EEE) ................................................................................... 37 Ehrlichia chafeensis .......................................................................................................... 38 Giardiasis .......................................................................................................................... 39 Gonorrhea ......................................................................................................................... 40 Group A Streptococcal disease, invasive .......................................................................... 41 Group B Streptococcal disease, invasive .......................................................................... 42 Haemophilus influenzae, invasive ..................................................................................... 43 Hemolytic Uremic Syndrome (HUS) .................................................................................. 44 Hepatitis A ......................................................................................................................... 45 Hepatitis B, acute .............................................................................................................. 46 Hepatitis B, chronic ........................................................................................................... 47 Hepatitis C, acute .............................................................................................................. 48 Hepatitis C, chronic ........................................................................................................... 49 HIV .................................................................................................................................... 50 Legionellosis ..................................................................................................................... 51 Listeriosis .......................................................................................................................... 52 Lyme disease .................................................................................................................... 53 Malaria .............................................................................................................................. 54 Meningococcal disease ..................................................................................................... 55 Pertussis ........................................................................................................................... 56 Powassan ......................................................................................................................... 57 Rabies, animal .................................................................................................................. 58 S. aureus, methicillin resistant (MRSA) ............................................................................. 59 S. aureus, vancomycin intermediate resistant (VISA) ........................................................ 60 Salmonellosis .................................................................................................................... 61 Shiga toxin-producing E. coli ............................................................................................. 62 Shigellosis ......................................................................................................................... 63 Spotted Fever Rickettsiosis (SFR) ..................................................................................... 64 Streptococcus pneumoniae, invasive ................................................................................ 65 Syphilis… .......................................................................................................................... 66 Tuberculosis ...................................................................................................................... 67 Varicella (Chickenpox) ...................................................................................................... 68 3 Vibriosis ............................................................................................................................ 69 West Nile virus (WNV) ....................................................................................................... 70 Appendices Appendix A: Workgroup Summaries ................................................................................. 71 Appendix B: Hepatitis C Enhanced Surveillance Project .................................................. 73 Appendix C: Increase in Hemolytic Uremic Syndrome Cases ........................................... 74 Appendix D: Cluster of Human Metapneumovirus Pneumonia Cases .............................. 75 Appendix E: Infectious Diseases in Shelter Settings. ........................................................ 76 Appendix F: Syphilis in Maine .........................................................................................
Load more

Recommended publications
  • 2016 New Jersey Reportable Communicable Disease Report (January 3, 2016 to December 31, 2016) (Excl
    10:34 Friday, June 30, 2017 1 2016 New Jersey Reportable Communicable Disease Report (January 3, 2016 to December 31, 2016) (excl. Sexually Transmitted Diseases, HIV/AIDS and Tuberculosis) (Refer to Technical Notes for Reporting Criteria) Case Jurisdiction Disease Counts STATE TOTAL AMOEBIASIS 98 STATE TOTAL ANTHRAX 0 STATE TOTAL ANTHRAX - CUTANEOUS 0 STATE TOTAL ANTHRAX - INHALATION 0 STATE TOTAL ANTHRAX - INTESTINAL 0 STATE TOTAL ANTHRAX - OROPHARYNGEAL 0 STATE TOTAL BABESIOSIS 174 STATE TOTAL BOTULISM - FOODBORNE 0 STATE TOTAL BOTULISM - INFANT 10 STATE TOTAL BOTULISM - OTHER, UNSPECIFIED 0 STATE TOTAL BOTULISM - WOUND 1 STATE TOTAL BRUCELLOSIS 1 STATE TOTAL CALIFORNIA ENCEPHALITIS(CE) 0 STATE TOTAL CAMPYLOBACTERIOSIS 1907 STATE TOTAL CHIKUNGUNYA 11 STATE TOTAL CHOLERA - O1 0 STATE TOTAL CHOLERA - O139 0 STATE TOTAL CREUTZFELDT-JAKOB DISEASE 4 STATE TOTAL CREUTZFELDT-JAKOB DISEASE - FAMILIAL 0 STATE TOTAL CREUTZFELDT-JAKOB DISEASE - IATROGENIC 0 STATE TOTAL CREUTZFELDT-JAKOB DISEASE - NEW VARIANT 0 STATE TOTAL CREUTZFELDT-JAKOB DISEASE - SPORADIC 2 STATE TOTAL CREUTZFELDT-JAKOB DISEASE - UNKNOWN 1 STATE TOTAL CRYPTOSPORIDIOSIS 198 STATE TOTAL CYCLOSPORIASIS 29 STATE TOTAL DENGUE FEVER - DENGUE 43 STATE TOTAL DENGUE FEVER - DENGUE-LIKE ILLNESS 3 STATE TOTAL DENGUE FEVER - SEVERE DENGUE 4 STATE TOTAL DIPHTHERIA 0 STATE TOTAL EASTERN EQUINE ENCEPHALITIS(EEE) 1 STATE TOTAL EBOLA 0 STATE TOTAL EHRLICHIOSIS/ANAPLASMOSIS - ANAPLASMA PHAGOCYTOPHILUM (PREVIOUSLY HGE) 109 STATE TOTAL EHRLICHIOSIS/ANAPLASMOSIS - EHRLICHIA CHAFFEENSIS (PREVIOUSLY
    [Show full text]
  • Joint Statement on Insect Repellents by EPA And
    Joint Statement on Insect Repellents from the Environmental Protection Agency and the Centers for Disease Control and Prevention July 17, 2014 The Environmental Protection Agency (EPA) and Centers for Disease Control and Prevention (CDC) are recommending that the public use insect repellents and take other precautions to avoid biting insects that carry serious diseases. The incidence of these diseases is on the rise. This joint statement discusses diseases that are transmitted by ticks and mosquitoes, the role of government in vector control and disease prevention, the history of repellents, how to use repellents as part of an integrated control program, and how to select and use a repellent. Introduction and Purpose CDC and EPA developed this joint statement to promote awareness of repellents and to highlight the effectiveness of repellents in preventing mosquito and tick bites. The agencies believe that promoting the use of repellents may reduce the impact of diseases and nuisance effects caused by these pests. Vector-borne diseases, such as those transmitted by mosquitoes and ticks, are among the world's leading causes of illness and death today. A wide variety of arthropods, including mosquitoes, ticks, fleas, black flies, sand flies, horse flies, stable flies, kissing bugs, lice and mites, feed on human blood. Among these, mosquitoes and ticks transmit some of the most serious vector- borne diseases both globally and within the United States. Diseases Transmitted by Mosquitoes and Ticks Mosquito-transmitted West Nile virus caused over 36,000 disease cases and 1,500 deaths in the United States between 1999 and 2012 (CDC, 2012). Mosquitoes also transmit other viruses that cause severe disease in the United States, including La Crosse encephalitis, eastern equine encephalitis and dengue.
    [Show full text]
  • HIV (Human Immunodeficiency Virus)
    TABLE OF CONTENTS AFRICAN TICK BITE FEVER .........................................................................................3 AMEBIASIS .....................................................................................................................4 ANTHRAX .......................................................................................................................5 ASEPTIC MENINGITIS ...................................................................................................6 BACTERIAL MENINGITIS, OTHER ................................................................................7 BOTULISM, FOODBORNE .............................................................................................8 BOTULISM, INFANT .......................................................................................................9 BOTULISM, WOUND .................................................................................................... 10 BOTULISM, OTHER ...................................................................................................... 11 BRUCELLOSIS ............................................................................................................. 12 CAMPYLOBACTERIOSIS ............................................................................................. 13 CHANCROID ................................................................................................................. 14 CHLAMYDIA TRACHOMATIS INFECTION .................................................................
    [Show full text]
  • Summer Safety Guide C L I N T O N C O U N T Y H E a L T H D E P a R T M E N T
    SUMMER SAFETY GUIDE C L I N T O N C O U N T Y H E A L T H D E P A R T M E N T S U M M E R 2 0 1 7 WHAT'S INSIDE... 2 7 W H A T ' S B I T I N G Y O U ? P R O T E C T Y O U R H O M E 3 8-9 M O S Q U I T O E S A N I M A L S A N D R A B I E S 4-5 10 T I C K S A N D L Y M E D I S E A S E B E D B U G S 6 11-12 P R O T E C T Y O U R S E L F S U N A N D W A T E R S A F E T Y WHAT'S BITING YOU? P R E V E N T I O N I S Y O U R B E S T D E F E N S E SUMMER HAS ARRIVED! THAT Mosquitoes West Nile virus (WNV) and Eastern MEANS SUN AND FUN, BUT IT equine encephalitis (EEE) are the most common diseases transmitted IS ALSO THE TIME OF YEAR Animals by local mosquitoes. There are no Wildlife is part of the beauty of our WHEN PEOPLE ARE MOST human vaccines for these diseases, Adirondack region, but animals are but there are simple steps you can best viewed from afar.
    [Show full text]
  • Outbreak of Powassan Encephalitis Maine and Vermont, 1999-2001
    FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION nal fluid (CSF) contained 40 white blood Her clinical examination showed agita- Outbreak of cells (WBCs)/mm3 (normal: Ͻ4/mm3) tion without confusion, ataxia, bilat- (87% lymphocytes) with elevated pro- eral lateral gaze palsy, and dysarthria. Powassan tein (96 mg/dL; normal: 20-50 mg/dL). CSF contained 148 WBCs/mm3 (46% Encephalitis— Magnetic resonance imaging (MRI) neutrophils, 40% lymphocytes). Dur- revealed parietal changes consistent with ing hospitalization, she developed al- Maine and Vermont, microvascular ischemia or demyelinat- tered mental status, generalized muscle 1999-2001 ing disease. No causes for his apparent weakness, and complete ophthalmople- stroke were found. After 22 days of hos- gia. An electroencephalogram (EEG) in- MMWR. 2001;50:761-764 pitalization, he was discharged to a reha- dicated diffuse encephalitis, and a MRI bilitation facility. Nearly 3 months after showed bilateral temporal lobe abnor- POWASSAN (POW) VIRUS, A NORTH symptom onset, he remains in the facil- malities consistent with microvascular American tickborne flavivirus related to ity and is unable to move his left arm or ischemia or demyelinating disease. Af- the Eastern Hemisphere’s tickborne en- leg. Serum specimens and CSF col- ter 13 days, she was transferred to a re- cephalitis viruses,1 was first isolated from lected 3 days after hospitalization habilitation facility where she re- a patient with encephalitis in 1958.1,2 revealed POW virus-specific IgM; neu- mained for 2 months. Nine months after During 1958-1998, 27 human POW en- tralizing antibody (1:640 titer) also was onset of symptoms, she was walking and cephalitis cases were reported from found in serum specimens.
    [Show full text]
  • Laboratory Reporting Reference Updated January 2020
    Laboratory Reporting Reference Updated January 2020 Report to MOH Report to CMOH Report to MOH Report to CMOH Disease / Pathogen Disease / Pathogen (or Designate) (or Designate) (or Designate) (or Designate) Aeromonas (Stool only) 48 48 Lymphogranuloma Venereum 48 to STI Director 48 Amoebiasis 48 48 Malaria 48 48 Anthrax FMP 48 Measles FMP 48 Arboviral Infections1 48 48 Meningococcal Disease, Invasive FMP 48 Bacillus cereus (Only stool or implicated food) 48 48 Methicillin Resistant Staphylococcus Aureus N/A 48 Botulism FMP 48 Mumps 48 48 Brucellosis 48 48 Norovirus 48 48 Campylobacteriosis 48 48 Paratyphoid Fever (Salmonella paratyphi A, B or C) FMP 48 Carbapenemase-Producing Organisms 48 48 Pertussis 48 48 Cerebrospinal Fluid Isolates N/A 48 Plague FMP 48 Chancroid 48 to STI Director 48 Pneumococcal Disease, Invasive (Streptococcus pneumoniae) 48 48 Chlamydia 48 to STI Director 48 Poliomyelitis FMP FMP Cholera (O1, O139) FMP 48 Psittacosis 48 48 Clostridium difficile – Associated Infection 48 48 Q fever 48 48 Clostridium perfringens (Only stool or implicated food) 48 48 Rabies FMP 48 Coronavirus, MERS/SARS FMP FMP Rare/Emerging Communicable Diseases2 FMP FMP Coronavirus, Novel FMP FMP Respiratory Syncytial Virus 48 48 Corynebacterium (C. Ulcerans or C. pseudotuberculosis) N/A 48 Rickettsial Infections (Spotted Fevers) 48 48 Creutzfeldt-Jakob disease (Includes 14-3-3 protein) 48 48 Rotavirus 48 48 Cryptosporidiosis 48 48 Rubella (Includes congenital) 48 48 Cyclosporiasis 48 48 Salmonellosis (Excludes paratyphi & typhi) 48 48 Cytomegalovirus,
    [Show full text]
  • Powassan Virus Experimental Infections in Three Wild Mammal Species
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln USDA National Wildlife Research Center - Staff U.S. Department of Agriculture: Animal and Publications Plant Health Inspection Service 2021 Powassan Virus Experimental Infections in Three Wild Mammal Species Nicole M. Nemeth Colorado State University, [email protected] J. Jeffrey Root USDA APHIS Wildlife Services Airn E. Hartwig Colorado State University Richard A. Bowen Colorado State University Angela M. Bosco-Lauth Colorado State University Follow this and additional works at: https://digitalcommons.unl.edu/icwdm_usdanwrc Part of the Natural Resources and Conservation Commons, Natural Resources Management and Policy Commons, Other Environmental Sciences Commons, Other Veterinary Medicine Commons, Population Biology Commons, Terrestrial and Aquatic Ecology Commons, Veterinary Infectious Diseases Commons, Veterinary Microbiology and Immunobiology Commons, Veterinary Preventive Medicine, Epidemiology, and Public Health Commons, and the Zoology Commons Nemeth, Nicole M.; Root, J. Jeffrey; Hartwig, Airn E.; Bowen, Richard A.; and Bosco-Lauth, Angela M., "Powassan Virus Experimental Infections in Three Wild Mammal Species" (2021). USDA National Wildlife Research Center - Staff Publications. 2444. https://digitalcommons.unl.edu/icwdm_usdanwrc/2444 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Animal and Plant Health Inspection Service at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in USDA National Wildlife Research Center - Staff Publications by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Am. J. Trop. Med. Hyg., 104(3), 2021, pp. 1048–1054 doi:10.4269/ajtmh.20-0105 Copyright © 2021 by The American Society of Tropical Medicine and Hygiene Powassan Virus Experimental Infections in Three Wild Mammal Species Nicole M.
    [Show full text]
  • A New Tick-Borne Encephalitis-Like Virus Infecting New England Deer Ticks, Ixodes Dammini1
    Dispatches A New Tick-borne Encephalitis-like Virus Infecting New England Deer Ticks, Ixodes dammini1 To determine if eastern North American Ixodes dammini, like related ticks in Eurasia, maintain tick-borne encephalitis group viruses, we analyzed ticks collected from sites where the agent of Lyme disease is zoonotic. Two viral isolates were obtained by inoculating mice with homogenates from tick salivary glands. The virus, which was described by reverse transcriptase polymerase chain reaction and direct sequencing of the amplification products, was similar to, but distinct from, Powassan virus and is provisionally named “deer tick virus.” Enzootic tick-borne encephalitis group viruses accompany the agents of Lyme disease, babesiosis, and granulocytic ehrlichiosis in a Holarctic assemblage of emergent deer tick pathogens. American zoonotic foci of the agents of Lyme humidified chamber until dissection, no more disease (Borrelia burgdorferi, a spirochete) and than 1 month after they were removed from hosts. human babesiosis (Babesia microti, a protozoon) Each field-derived tick was dissected into a were first recognized in coastal New England and drop of sterile Hanks Balanced Salt Solution with the northern Great Plains during the 1960s and 15% fetal bovine serum (HBSS/FBS), and one of 1970s (1). Human granulocytic ehrlichiosis (caused its salivary glands was stained by the Feulgen by rickettsia, Ehrlichia microti or Ehrlichia reaction (8). The corresponding gland was pooled phagocytophila/equi [2]) joined this guild (3) of in 0.5 mL HBSS/FBS with that from four other deer tick-transmitted pathogens (Ixodes dammini ticks and was homogenized; 0.4 mL of each pool [4,5]) during the 1990s.
    [Show full text]
  • North American Deer Mice Are Susceptible to SARS (Biorxiv)
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.25.221291; this version posted July 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 North American deer mice are susceptible to SARS-CoV-2 2 3 4 5 Bryan D. Griffin1,, Mable Chan1, Nikesh Tailor1, Emelissa J. Mendoza1, Anders Leung1, Bryce 6 M. Warner1, 2, Ana T. Duggan3, Estella Moffat4, Shihua He1, Lauren Garnett1, 2, Kaylie N. Tran1, 7 Logan Banadyga1, Alixandra Albietz1, Kevin Tierney1, Jonathan Audet1, Alexander Bello1, 8 Robert Vendramelli1, Amrit S. Boese1, Lisa Fernando1, L. Robbin Lindsay1, 5, Claire M. Jardine6, 9 Heidi Wood1, Guillaume Poliquin2, 7, 8, James E. Strong1, 2, 7 , Michael Drebot1, 2, David 10 Safronetz1, 2, Carissa Embury-Hyatt4, Darwyn Kobasa1,2, * 11 12 13 14 15 Affiliations: 16 17 1Zoonotic Diseases and Special Pathogens Program, National Microbiology Laboratory, Public 18 Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2 19 2Department of Medical Microbiology and Infectious Diseases, College of Medicine, Faculty of 20 Health Sciences, University of Manitoba, 745 Bannatyne Avenue, Winnipeg, Manitoba, Canada 21 R3E 0J9 22 3Science Technology Cores and Services, National Microbiology Laboratory, Public Health 23 Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3R2. 24 4National Centre for Foreign Animal
    [Show full text]
  • Transmission of Diseases Via Animals and Insects Zoonotic Infections
    7/13/2011 Transmission of Diseases via Animals and Insects Greta Schuster, PhD. Associate Professor, IPM Texas A&M University ‐ Kingsville Environmental and Children’s Health Training Texas AgriLife Research & Extension Center Weslaco, TX June 23, 2011 Zoonotic infections • Zoonoses are infections that can be passed from animals to humans. • Sources of zoonoses include cattle, sheep, horses, pigs, dogs, cats, chickens, native birds, kangaroos, wild animals, rodents, reptiles (including turtles and tortoises) and bats. 1 7/13/2011 • A zoonotic disease is a disease that can be shared between animals and people. • A person may become infected with an animal disease indirectly (from the environment or through flies, mosquitoes, ticks, and fleas) or directly (through close contact between animals and people). Ways Zoonotic Diseases Are Spread • Fecal‐oral route ‐Animal feces may pass directly from soiled hands to mouth, or indirectly by way of objects, surfaces, water or food contaminated with feces. • Inhalation ‐ Humans may breathe in droplets containing harmful organisms (aerosols) originating from an infected animal. 2 7/13/2011 Ways Zoonotic Diseases Are Spread • Ingestion ‐ Consuming contaminated food or water may lead to illness –for example, consumption of unpasteurized milk from an infected animal or eating animal feed. • Vector transmission Vector • Biological Vector –e.g. mosquitoes that transmit WNV • Mechanical Vector –insect that carries pathogen on body surface or mouthparts, or even within the gut but which does not allow for multiplication of the pathogen. House flies – Think dirty needle! 3 7/13/2011 Vector‐borne Diseases • A vector‐borne disease is one in which the pathogenic microorganism is transmitted from an infected individual to another individual by an arthropod or other agent, sometimes with other animals serving as intermediary hosts.
    [Show full text]
  • Tick-Borne Encephalitis Virus Complex • Aerosol Hazard in Laboratory
    Tick-Borne Encephalitis Virus Complex • Aerosol hazard in laboratory Disease Agents: Likelihood of Secondary Transmission: • Tick-borne encephalitis virus (TBEV) • Unlikely • Powassan virus (POWV) / deer tick virus (DTV) At-Risk Populations: • Other potentially relevant members of the TBEV complex include Kyasanur Forest disease virus (KFDV) and its related • Forestry workers, farmers, military, outdoor enthusiasts variant Alkhurma virus (ALKV), and Omsk hemorrhagic Vector and Reservoir Involved: fever virus (OHFV) • Ixodes ricinus (Western Europe); I. persulcatus (eastern Disease Agent Characteristics: Eurasia); I. ovatus (China and Japan); I. cookei (North • Family: Flaviviridae; Genus: Flavivirus; Species: TBEV (sub- America) types: European, Far Eastern, and Siberian); POWV/DTV • Dermacentor species and Haemaphysalis species also impli- • Virion morphology and size: Enveloped, polyhedral nucleo- cated vectors in Ixodes-free areas capsid symmetry, spherical particles, 40-60 nm in diameter • Maintained in nature in small wild vertebrate hosts (rodents • Nucleic acid: Linear, positive-sense, single-stranded RNA, and insectivores); large mammals, such as goats, sheep, and ~11.0 kb in length cattle are a less important source of infection • Physicochemical properties: Nonionic detergents solubilize • POWV is maintained primarily in a woodchuck-mustelid-I. the entire envelope; infectivity sensitive to acid pH and high cookei cycle; humans infrequently come into contact with temperatures (total inactivation at 56°C for 30 min); virus infectious ticks that are found only rarely outside of the stable at low temperatures, especially at -60°C or below; burrows of their host animal; generations of ticks are associ- aerosol hazard noted; virus inactivated by UV light, gamma- ated with a single animal. This tick behavior is referred to as irradiation and disinfectants (relatively more resistant than nidiculous.
    [Show full text]
  • Arboviral Infection Surveillance Protocol
    March 2017 Arboviral Infection Surveillance Protocol Arboviruses endemic to the U.S. include Eastern equine encephalitis virus (EEE), La Crosse encephalitis virus (LAC), Saint Louis encephalitis virus (SLE), West Nile virus (WNV), Western equine encephalitis virus (WEE), and Powassan encephalitis virus (POW), a tickborne arboviral disease that has not been reported in humans in West Virginia. Chikungunya is an arbovirus that is associated with travel to an endemic country. These arboviral diseases (and those included in the most recent CDC case definition) are reportable to the local health department where the patient resides within one week. Dengue, yellow fever, and Zika virus disease have earlier notification timelines and, therefore, have their own disease surveillance protocols. Provider Responsibilities For reporting of endemic arboviral diseases (WNV, LAC, SLE, EEE): 1. Report suspect and confirmed cases of arbovirus infection (including copies of lab results) to the local health department within one week of diagnosis. Supply requested clinical information to the local health department to assist with case ascertainment. 2. Assure appropriate testing is completed for patients with suspected arboviral disease infection. The preferred diagnostic test is testing for virus-specific IgM antibodies in serum or cerebrospinal fluid (CSF). In West Virginia, appropriate endemic arbovirus testing should include EEE, LAC, SLE, and WNV. Testing for LAC, SLE, and WNV is available at no cost to the patient through the West Virginia Office of Laboratory Services (OLS). Confirmatory testing may be conducted at the Centers for Disease Control and Prevention (CDC). For reporting of non-endemic arboviral diseases (e.g. chikungunya): 1. Report suspect and confirmed cases of arbovirus infection (including copies of lab results) to the local health department within one week of diagnosis.
    [Show full text]